PDPs Applaud Japan’s First Public-Private Partnership to Spearhead Innovation in Global Health

A new public-private partnership of the Japanese Government, the Bill &Melinda Gates Foundation and a group of private pharmaceutical companies seeks to foster and harness Japanese innovation to address diseases that disproportionately affect low- and middle-income countries.

The number of polio cases has plummeted in the last 25 years, from 300,000 to less than 300. Even so, last May the World Health Organization declared that global eradication of polio, reaching that last 0.1 percent, was a “programmatic emergency for global public health.”

In a recent blog post, Bill Gates describes his visit to Ghana, where he hoped to learn more about the country’s health delivery systems.

Today, Sabin President Dr. Peter Hotez contributed a story to Foreign Policy about how little known neglected tropical diseases (NTDs) are wreaking havoc in some of the world's wealthiest nations. This and other stories in today's News Roundup.
Today the Decade of Vaccines (DoV) Collaboration released the final, illustrated version of the Global Vaccine Action Plan (GVAP), with a foreword by the DoV Collaboration Leadership Council, photographs, charts and important annexes.
When discussing public health campaigns and disease prevention, most people want to immediately jump to the solution – we want a vaccine, a cure, a narrative – so we can stop the cycle of disease and suffering. But we must remember to crawl before we walk, and this cliché could not ring more true than in the world of disease monitoring and surveillance, particularly for a disease like pneumococcal, a deadly bacterial infection that kills more than 1.6 million people annually, including half a million children.
Earlier this month, the Coalition against Typhoid (CaT), along with partners at the Bangladesh Pediatric Association, the International Vaccine Institute andthe International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), convened the 8th International Conference on Typhoid Fever and Other Invasive Salmonelloses in Dhaka, Bangladesh. Researchers and health professionals, as well as local, national and international policy makers were in attendance.
From 19-22 February 2013, Sabin Executive Vice-President Dr. Ciro de Quadros and Program Officer Brian Shaw participated in the SEARO Regional Consultation on Measles Elimination and Rubella/CRS Control, held in Kathmandu, Nepal. As a member of the Measles Rubella Initiative (MRI), Sabin is committed to the elimination of measles, rubella & congenital rubella syndrome (CRS).
Rwanda’s measles-rubella vaccination campaign, which is being launched today, is the beginning of an effort to vaccinate more than 700 million children under 15 years of age against two disabling and deadly diseases.

Pages

Subscribe to RSS - Vaccine Advocacy and Education